• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌:二十年回顾

Helicobacter pylori: 20 years on.

作者信息

Marshall Barry

机构信息

Helicobacter pylori Research Laboratory, Queen Elizabeth ll Medical Centre, Nedlands, Western Australia.

出版信息

Clin Med (Lond). 2002 Mar-Apr;2(2):147-52. doi: 10.7861/clinmedicine.2-2-147.

DOI:10.7861/clinmedicine.2-2-147
PMID:11991099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4952378/
Abstract

Helicobacters are a new genus of bacteria, inhabiting the interface between mucosa and lumen of the gut. Microaerophilic, spiral, flagellated and urease positive, they possess features necessary for colonisation of the juxtamucosal mucus environment. Helicobacter pylori is the major pathogenic species. Once attached to the gastric epithelial cells, it incites an immune response characterised histologically by the development of active gastritis and immunologically by the presence of specific IgG. Persistence of infection is ensured by attachment to tissue antigens (eg Lewis B), a vacuolating toxin (VacA) which assists the free passage of urea through epithelial cells, and a cytotoxin (CagA) which is actually injected into the epithelial cells via a Type IV secretion system. Finally, during the typical lifelong chronic infection, two important diseases occur. H. pylori alters gastric physiology to cause acid hypersecretion and peptic ulcer. Secondly, it damages the acid secreting mucosa leading to atrophic gastritis and gastric cancer risk.

摘要

幽门螺杆菌是一种新的细菌属,栖息于肠道黏膜与管腔的界面。它们是微需氧菌,呈螺旋状,有鞭毛且尿素酶呈阳性,具备在近黏膜黏液环境中定殖所需的特征。幽门螺杆菌是主要的致病菌种。一旦附着于胃上皮细胞,它就会引发免疫反应,组织学上表现为活动性胃炎的发展,免疫学上表现为特异性IgG的存在。通过附着于组织抗原(如Lewis B)、一种协助尿素通过上皮细胞自由通透的空泡毒素(VacA)以及一种实际上通过IV型分泌系统注入上皮细胞的细胞毒素(CagA)来确保感染的持续存在。最后,在典型的终身慢性感染过程中,会发生两种重要疾病。幽门螺杆菌改变胃生理,导致胃酸分泌过多和消化性溃疡。其次,它会损害分泌酸的黏膜,导致萎缩性胃炎和胃癌风险。

相似文献

1
Helicobacter pylori: 20 years on.幽门螺杆菌:二十年回顾
Clin Med (Lond). 2002 Mar-Apr;2(2):147-52. doi: 10.7861/clinmedicine.2-2-147.
2
[The heterogeneity of genetic variants of Helicobacter pylori in patients with various acid-related diseases].[不同酸相关性疾病患者幽门螺杆菌基因变异的异质性]
Eksp Klin Gastroenterol. 2014(11):8-13.
3
[Molecular detection of Helicobacter pylori vacA and cagA genes in gastric tissue specimens of patients with peptic ulcer disease and non-ulcer dyspepsia].[消化性溃疡病和非溃疡性消化不良患者胃组织标本中幽门螺杆菌vacA和cagA基因的分子检测]
Mikrobiyol Bul. 2011 Jan;45(1):11-20.
4
The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.幽门螺杆菌毒力因子与 PD1:PD-L1 免疫检查点抑制剂在胃癌进展中的相互作用。
Immunol Lett. 2021 Nov;239:1-11. doi: 10.1016/j.imlet.2021.06.009. Epub 2021 Aug 5.
5
Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.幽门螺杆菌毒力因子 CagA 和 VacA 对胃肠道疾病发病机制的影响。
Microb Pathog. 2018 Apr;117:43-48. doi: 10.1016/j.micpath.2018.02.016. Epub 2018 Feb 9.
6
Helicobacter pylori and gastric epithelial cells: from gastritis to cancer.幽门螺杆菌与胃上皮细胞:从胃炎到癌症
J Exp Clin Cancer Res. 2005 Sep;24(3):337-45.
7
The physiology and metabolism of the human gastric pathogen Helicobacter pylori.人类胃部病原体幽门螺杆菌的生理学与代谢
Adv Microb Physiol. 1998;40:137-89. doi: 10.1016/s0065-2911(08)60131-9.
8
CagA and cytotoxicity of Helicobacter pylori are not markers of peptic ulcer in Japanese patients.在日本患者中,幽门螺杆菌的CagA和细胞毒性不是消化性溃疡的标志物。
Helicobacter. 1999 Mar;4(1):1-6. doi: 10.1046/j.1523-5378.1999.09003.x.
9
No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil.在巴西,幽门螺杆菌的babA2与vacA和cagA基因型以及消化性溃疡疾病患者的胃炎分级之间无相关性。
Helicobacter. 2005 Dec;10(6):601-8. doi: 10.1111/j.1523-5378.2005.00360.x.
10
Virulence genes of Helicobacter pylori in gastritis, peptic ulcer and gastric cancer in Laos.老挝胃炎、消化性溃疡和胃癌中幽门螺杆菌的毒力基因
Asian Pac J Cancer Prev. 2014;15(20):9027-31. doi: 10.7314/apjcp.2014.15.20.9027.

引用本文的文献

1
Microbiota mechanisms in cancer progression and therapy.微生物群在癌症进展和治疗中的作用机制。
Cell Chem Biol. 2025 May 15;32(5):653-677. doi: 10.1016/j.chembiol.2025.04.005. Epub 2025 May 6.
2
Why has epidemiology not (yet) succeeded in identifying the origin of the asthma epidemic?为什么流行病学尚未成功确定哮喘流行的起源?
Int J Epidemiol. 2023 Aug 2;52(4):974-983. doi: 10.1093/ije/dyad035.
3
Enhanced enzymatic production of cholesteryl 6'-acylglucoside impairs lysosomal degradation for the intracellular survival of Helicobacter pylori.增强型胆甾醇 6'-酰基葡萄糖苷酶的产生会损害溶酶体降解,从而促进幽门螺杆菌的细胞内生存。
J Biomed Sci. 2021 Oct 27;28(1):72. doi: 10.1186/s12929-021-00768-w.
4
Persister cells as a possible cause of antibiotic therapy failure in .作为[具体疾病或情况未给出]中抗生素治疗失败可能原因的持留菌
JGH Open. 2021 Mar 18;5(4):493-497. doi: 10.1002/jgh3.12527. eCollection 2021 Apr.
5
Cholestenone functions as an antibiotic against by inhibiting biosynthesis of the cell wall component CGL.胆甾酮可通过抑制细胞壁成分 CGL 的生物合成来发挥对抗 的作用。
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16). doi: 10.1073/pnas.2016469118.
6
: Perturbation and restoration of gut microbiome.肠道微生物组的扰动与恢复。
J Biosci. 2020;45(1). doi: 10.1007/s12038-020-00078-7.
7
The Physiology of the Gastric Parietal Cell.胃壁细胞的生理学。
Physiol Rev. 2020 Apr 1;100(2):573-602. doi: 10.1152/physrev.00016.2019. Epub 2019 Oct 31.
8
Clinical Evaluation of CA72-4 for Screening Gastric Cancer in A Healthy Population: A Multicenter Retrospective Study.CA72-4在健康人群中筛查胃癌的临床评估:一项多中心回顾性研究
Cancers (Basel). 2019 May 27;11(5):733. doi: 10.3390/cancers11050733.
9
Probiotic spp. act Against -induced Inflammation.益生菌属对抗诱导性炎症。
J Clin Med. 2019 Jan 14;8(1):90. doi: 10.3390/jcm8010090.
10
Microbial communities in different regions of the gastrointestinal tract in East Asian finless porpoises (Neophocaena asiaeorientalis sunameri).东亚江豚(Neophocaena asiaeorientalis sunameri)胃肠道不同区域的微生物群落。
Sci Rep. 2018 Sep 20;8(1):14142. doi: 10.1038/s41598-018-32512-0.